Post-Brexit, the UK has embraced new genomic techniques (NGTs), breaking from the EU’s strict biotech rules. Seed World’s expert panel—Jan Gottlieb, Nigel Moore and Katie Davis—explores how this regulatory shift will impact Europe’s competitiveness, farmers, researchers and global trade. A must-watch discussion for anyone tracking gene editing, plant breeding and the future of agricultural innovation.
The post NGTs at a Crossroads: The UK Steps Forward, Can the EU Keep Up? appeared first on Seed World.
For decades, European biotech has been shaped by some of the strictest regulations in the world. Post-Brexit, the UK had a choice. In a major departure from the EU, England chose to open the door to NGTs.
What does this mean for Europe? For farmers? For global trade and competitiveness? And can the EU afford to stand still while the UK moves ahead?
Seed World assembled an expert panel to break down what’s happening now and what’s coming next:
- From Denmark, Jan Gottlieb — Commercial Lead and Co-Founder of Traitomic, part of the Carlsberg Group.
- From the UK, Nigel Moore, Head of Food Ingredients at KWS Group.
- And bringing a global perspective from her work across North America, Europe and Latin America, Katie Davis, who leads Global Regulatory, Government Affairs and Compliance at CIBUS.
In this discussion, we explore the real impacts of regulatory divergence, the opportunities and risks for researchers and farmers, what policymakers should be watching, and how Europe’s next decisions could shape agricultural innovation for the next decade.
If you’re following the future of gene editing, plant breeding, and global ag policy, this conversation is essential viewing.
The post NGTs at a Crossroads: The UK Steps Forward, Can the EU Keep Up? appeared first on Seed World.